LIGAND PHARMACEUTICALS INC ($LGND)
Reardon Andrew โ CLO & Secretary
Shares
5,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: 1.46
Revenue:Est: $55.59M
Transaction Details
| Insider | Reardon Andrew |
|---|---|
| Title | CLO & Secretary |
| Transaction Date | Mar 4, 2026 |
| Expiration Date | Aug 1, 2032 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Employee Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Purchased | 5,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 54,444 |
| Derivative | Derivative |
| Accession Number | 0002001011-26-000024 |
| Document | View SEC Filing |